nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—ADRA1B—vas deferens—urinary bladder cancer	0.163	0.308	CbGeAlD
Phenoxybenzamine—SLC22A2—Cisplatin—urinary bladder cancer	0.0456	0.543	CbGbCtD
Phenoxybenzamine—CYP3A4—Thiotepa—urinary bladder cancer	0.0263	0.314	CbGbCtD
Phenoxybenzamine—ADRA1D—prostate gland—urinary bladder cancer	0.0142	0.0269	CbGeAlD
Phenoxybenzamine—CYP3A4—urine—urinary bladder cancer	0.0136	0.0258	CbGeAlD
Phenoxybenzamine—CALM3—prostate gland—urinary bladder cancer	0.0111	0.021	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—urinary bladder cancer	0.0105	0.0198	CbGeAlD
Phenoxybenzamine—SLC22A2—renal system—urinary bladder cancer	0.0104	0.0196	CbGeAlD
Phenoxybenzamine—SLC22A3—prostate gland—urinary bladder cancer	0.0103	0.0194	CbGeAlD
Phenoxybenzamine—ADRA1B—renal system—urinary bladder cancer	0.00993	0.0188	CbGeAlD
Phenoxybenzamine—ADRA1D—urethra—urinary bladder cancer	0.00954	0.018	CbGeAlD
Phenoxybenzamine—CALM3—seminal vesicle—urinary bladder cancer	0.0094	0.0178	CbGeAlD
Phenoxybenzamine—CALM2—prostate gland—urinary bladder cancer	0.00872	0.0165	CbGeAlD
Phenoxybenzamine—SLC22A3—seminal vesicle—urinary bladder cancer	0.00869	0.0164	CbGeAlD
Phenoxybenzamine—CALM1—prostate gland—urinary bladder cancer	0.00868	0.0164	CbGeAlD
Phenoxybenzamine—ADRA1A—prostate gland—urinary bladder cancer	0.00818	0.0155	CbGeAlD
Phenoxybenzamine—CALM3—smooth muscle tissue—urinary bladder cancer	0.00787	0.0149	CbGeAlD
Phenoxybenzamine—ADRA2C—prostate gland—urinary bladder cancer	0.0078	0.0147	CbGeAlD
Phenoxybenzamine—ADRA1D—female reproductive system—urinary bladder cancer	0.00778	0.0147	CbGeAlD
Phenoxybenzamine—CALM3—urethra—urinary bladder cancer	0.00744	0.0141	CbGeAlD
Phenoxybenzamine—CALM2—seminal vesicle—urinary bladder cancer	0.00738	0.014	CbGeAlD
Phenoxybenzamine—SLC22A1—renal system—urinary bladder cancer	0.00733	0.0139	CbGeAlD
Phenoxybenzamine—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.00727	0.0138	CbGeAlD
Phenoxybenzamine—CYP3A4—Etoposide—urinary bladder cancer	0.00714	0.0851	CbGbCtD
Phenoxybenzamine—SLC22A3—renal system—urinary bladder cancer	0.007	0.0132	CbGeAlD
Phenoxybenzamine—SLC22A3—urethra—urinary bladder cancer	0.00688	0.013	CbGeAlD
Phenoxybenzamine—ADRA2C—seminal vesicle—urinary bladder cancer	0.0066	0.0125	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—urinary bladder cancer	0.00641	0.0121	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—urinary bladder cancer	0.00638	0.0121	CbGeAlD
Phenoxybenzamine—Benzphetamine—POR—urinary bladder cancer	0.00638	0.276	CrCbGaD
Phenoxybenzamine—ADRA2A—prostate gland—urinary bladder cancer	0.00622	0.0118	CbGeAlD
Phenoxybenzamine—CALM2—smooth muscle tissue—urinary bladder cancer	0.00618	0.0117	CbGeAlD
Phenoxybenzamine—CALM1—smooth muscle tissue—urinary bladder cancer	0.00615	0.0116	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—urinary bladder cancer	0.00601	0.0114	CbGeAlD
Phenoxybenzamine—CALM2—renal system—urinary bladder cancer	0.00595	0.0112	CbGeAlD
Phenoxybenzamine—CALM1—renal system—urinary bladder cancer	0.00592	0.0112	CbGeAlD
Phenoxybenzamine—CALM2—urethra—urinary bladder cancer	0.00584	0.011	CbGeAlD
Phenoxybenzamine—CALM1—urethra—urinary bladder cancer	0.00581	0.011	CbGeAlD
Phenoxybenzamine—SLC22A3—female reproductive system—urinary bladder cancer	0.00561	0.0106	CbGeAlD
Phenoxybenzamine—ADRA1A—renal system—urinary bladder cancer	0.00558	0.0105	CbGeAlD
Phenoxybenzamine—CALM3—vagina—urinary bladder cancer	0.00548	0.0104	CbGeAlD
Phenoxybenzamine—ADRA2C—renal system—urinary bladder cancer	0.00531	0.01	CbGeAlD
Phenoxybenzamine—SLC22A1—vagina—urinary bladder cancer	0.00531	0.01	CbGeAlD
Phenoxybenzamine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00526	0.00995	CbGeAlD
Phenoxybenzamine—ADRA2C—urethra—urinary bladder cancer	0.00522	0.00987	CbGeAlD
Phenoxybenzamine—SLC22A3—vagina—urinary bladder cancer	0.00507	0.00959	CbGeAlD
Phenoxybenzamine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00487	0.058	CbGbCtD
Phenoxybenzamine—CALM2—female reproductive system—urinary bladder cancer	0.00476	0.00901	CbGeAlD
Phenoxybenzamine—CALM1—female reproductive system—urinary bladder cancer	0.00474	0.00896	CbGeAlD
Phenoxybenzamine—CALM2—vagina—urinary bladder cancer	0.00431	0.00814	CbGeAlD
Phenoxybenzamine—CALM1—vagina—urinary bladder cancer	0.00429	0.00811	CbGeAlD
Phenoxybenzamine—ADRA2A—urethra—urinary bladder cancer	0.00417	0.00788	CbGeAlD
Phenoxybenzamine—Ospemifene—ESR1—urinary bladder cancer	0.00411	0.178	CrCbGaD
Phenoxybenzamine—ADRA2C—vagina—urinary bladder cancer	0.00385	0.00728	CbGeAlD
Phenoxybenzamine—CALM3—lymph node—urinary bladder cancer	0.00355	0.00671	CbGeAlD
Phenoxybenzamine—ADRA2A—female reproductive system—urinary bladder cancer	0.0034	0.00642	CbGeAlD
Phenoxybenzamine—Toremifene—ESR1—urinary bladder cancer	0.00335	0.145	CrCbGaD
Phenoxybenzamine—CYP3A4—renal system—urinary bladder cancer	0.00334	0.00631	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—urinary bladder cancer	0.00328	0.0062	CbGeAlD
Phenoxybenzamine—ADRA2A—vagina—urinary bladder cancer	0.00307	0.00581	CbGeAlD
Phenoxybenzamine—Clomifene—ESR1—urinary bladder cancer	0.0029	0.125	CrCbGaD
Phenoxybenzamine—CALM2—lymph node—urinary bladder cancer	0.00279	0.00527	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—urinary bladder cancer	0.00277	0.00524	CbGeAlD
Phenoxybenzamine—CYP3A4—female reproductive system—urinary bladder cancer	0.00267	0.00506	CbGeAlD
Phenoxybenzamine—ADRA2C—lymph node—urinary bladder cancer	0.00249	0.00471	CbGeAlD
Phenoxybenzamine—Tamoxifen—ESR2—urinary bladder cancer	0.00217	0.0941	CrCbGaD
Phenoxybenzamine—ADRA2A—lymph node—urinary bladder cancer	0.00199	0.00376	CbGeAlD
Phenoxybenzamine—Fenoprofen—PTGS2—urinary bladder cancer	0.00158	0.0683	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—urinary bladder cancer	0.00134	0.058	CrCbGaD
Phenoxybenzamine—Phenylbutazone—PTGS2—urinary bladder cancer	0.00126	0.0547	CrCbGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HRAS—urinary bladder cancer	4.03e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HRAS—urinary bladder cancer	4.03e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MMP9—urinary bladder cancer	4.03e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL8—urinary bladder cancer	4.02e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CDKN1A—urinary bladder cancer	4.01e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PTEN—urinary bladder cancer	4e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ESR1—urinary bladder cancer	4e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HRAS—urinary bladder cancer	3.99e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FGFR3—urinary bladder cancer	3.98e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FGFR3—urinary bladder cancer	3.98e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL2—urinary bladder cancer	3.98e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL2—urinary bladder cancer	3.98e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL8—urinary bladder cancer	3.97e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—urinary bladder cancer	3.96e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—urinary bladder cancer	3.96e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—ERBB2—urinary bladder cancer	3.96e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—EP300—urinary bladder cancer	3.96e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HRAS—urinary bladder cancer	3.94e-05	0.000108	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—ERBB2—urinary bladder cancer	3.9e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CDKN1A—urinary bladder cancer	3.88e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PTEN—urinary bladder cancer	3.87e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	3.87e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ESR1—urinary bladder cancer	3.87e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ESR1—urinary bladder cancer	3.87e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—EP300—urinary bladder cancer	3.85e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL2—urinary bladder cancer	3.84e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	3.84e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	3.84e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EP300—urinary bladder cancer	3.82e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL2—urinary bladder cancer	3.79e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	3.79e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	3.77e-05	0.000104	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	3.76e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL8—urinary bladder cancer	3.75e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CDKN1A—urinary bladder cancer	3.75e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CDKN1A—urinary bladder cancer	3.75e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCND1—urinary bladder cancer	3.74e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PTEN—urinary bladder cancer	3.74e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PTEN—urinary bladder cancer	3.74e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	3.74e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—urinary bladder cancer	3.73e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—SRC—urinary bladder cancer	3.71e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.71e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCND1—urinary bladder cancer	3.7e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL8—urinary bladder cancer	3.7e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EP300—urinary bladder cancer	3.69e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—EP300—urinary bladder cancer	3.69e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—urinary bladder cancer	3.67e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MMP9—urinary bladder cancer	3.64e-05	9.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.62e-05	9.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PTEN—urinary bladder cancer	3.61e-05	9.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MMP9—urinary bladder cancer	3.59e-05	9.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—SRC—urinary bladder cancer	3.59e-05	9.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL2—urinary bladder cancer	3.59e-05	9.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CDKN1A—urinary bladder cancer	3.58e-05	9.83e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CDKN1A—urinary bladder cancer	3.58e-05	9.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTEN—urinary bladder cancer	3.57e-05	9.81e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EP300—urinary bladder cancer	3.57e-05	9.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EP300—urinary bladder cancer	3.57e-05	9.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PTEN—urinary bladder cancer	3.57e-05	9.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	3.56e-05	9.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	3.53e-05	9.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CREBBP—urinary bladder cancer	3.5e-05	9.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCND1—urinary bladder cancer	3.5e-05	9.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	3.47e-05	9.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—SRC—urinary bladder cancer	3.47e-05	9.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—SRC—urinary bladder cancer	3.47e-05	9.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CDKN1A—urinary bladder cancer	3.46e-05	9.51e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CDKN1A—urinary bladder cancer	3.46e-05	9.51e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	3.46e-05	9.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF1—urinary bladder cancer	3.46e-05	9.5e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTEN—urinary bladder cancer	3.46e-05	9.49e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTEN—urinary bladder cancer	3.46e-05	9.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EP300—urinary bladder cancer	3.45e-05	9.47e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—EGFR—urinary bladder cancer	3.44e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	3.44e-05	9.45e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—urinary bladder cancer	3.43e-05	9.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EP300—urinary bladder cancer	3.41e-05	9.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EP300—urinary bladder cancer	3.4e-05	9.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MMP9—urinary bladder cancer	3.4e-05	9.33e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CREBBP—urinary bladder cancer	3.39e-05	9.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CREBBP—urinary bladder cancer	3.39e-05	9.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CDKN1A—urinary bladder cancer	3.38e-05	9.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PTEN—urinary bladder cancer	3.38e-05	9.27e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—SRC—urinary bladder cancer	3.35e-05	9.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF1—urinary bladder cancer	3.35e-05	9.19e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF1—urinary bladder cancer	3.35e-05	9.19e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	3.34e-05	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—EGFR—urinary bladder cancer	3.33e-05	9.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—EGFR—urinary bladder cancer	3.33e-05	9.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.33e-05	9.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	3.33e-05	9.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	3.32e-05	9.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—urinary bladder cancer	3.32e-05	9.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—urinary bladder cancer	3.32e-05	9.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—SRC—urinary bladder cancer	3.31e-05	9.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—SRC—urinary bladder cancer	3.31e-05	9.09e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EP300—urinary bladder cancer	3.3e-05	9.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EP300—urinary bladder cancer	3.3e-05	9.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	3.28e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	3.28e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	3.26e-05	8.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	3.25e-05	8.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—KRAS—urinary bladder cancer	3.25e-05	8.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EP300—urinary bladder cancer	3.22e-05	8.84e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.22e-05	8.83e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—SRC—urinary bladder cancer	3.21e-05	8.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—SRC—urinary bladder cancer	3.21e-05	8.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RHOA—urinary bladder cancer	3.17e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	3.17e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—KRAS—urinary bladder cancer	3.15e-05	8.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—KRAS—urinary bladder cancer	3.15e-05	8.64e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EGFR—urinary bladder cancer	3.15e-05	8.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	3.14e-05	8.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—SRC—urinary bladder cancer	3.13e-05	8.6e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—EP300—urinary bladder cancer	3.13e-05	8.59e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.09e-05	8.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	3.08e-05	8.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	3.07e-05	8.44e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RHOA—urinary bladder cancer	3.07e-05	8.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RHOA—urinary bladder cancer	3.07e-05	8.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	3.06e-05	8.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	3.05e-05	8.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EGFR—urinary bladder cancer	3.04e-05	8.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EGFR—urinary bladder cancer	3.04e-05	8.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	3.03e-05	8.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—urinary bladder cancer	3e-05	8.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTEN—urinary bladder cancer	2.99e-05	8.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—urinary bladder cancer	2.97e-05	8.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—urinary bladder cancer	2.97e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	2.97e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—urinary bladder cancer	2.97e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.96e-05	8.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	2.95e-05	8.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—urinary bladder cancer	2.94e-05	8.07e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB2—urinary bladder cancer	2.93e-05	8.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	2.91e-05	8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—urinary bladder cancer	2.9e-05	7.98e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—urinary bladder cancer	2.9e-05	7.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—urinary bladder cancer	2.89e-05	7.95e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—urinary bladder cancer	2.89e-05	7.95e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.87e-05	7.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—urinary bladder cancer	2.87e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—urinary bladder cancer	2.87e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—urinary bladder cancer	2.87e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—urinary bladder cancer	2.87e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—urinary bladder cancer	2.85e-05	7.84e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.84e-05	7.8e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.84e-05	7.8e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	2.84e-05	7.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB2—urinary bladder cancer	2.84e-05	7.79e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.84e-05	7.79e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	2.81e-05	7.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—urinary bladder cancer	2.81e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—urinary bladder cancer	2.81e-05	7.72e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—urinary bladder cancer	2.81e-05	7.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—urinary bladder cancer	2.78e-05	7.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—urinary bladder cancer	2.78e-05	7.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—urinary bladder cancer	2.76e-05	7.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	2.76e-05	7.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—urinary bladder cancer	2.76e-05	7.58e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—urinary bladder cancer	2.76e-05	7.58e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	2.76e-05	7.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.75e-05	7.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—urinary bladder cancer	2.74e-05	7.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—urinary bladder cancer	2.74e-05	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	2.74e-05	7.53e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—urinary bladder cancer	2.74e-05	7.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	2.74e-05	7.52e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	2.73e-05	7.5e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.72e-05	7.47e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	2.7e-05	7.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—urinary bladder cancer	2.69e-05	7.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.69e-05	7.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—urinary bladder cancer	2.67e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.67e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.67e-05	7.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—urinary bladder cancer	2.66e-05	7.3e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—urinary bladder cancer	2.65e-05	7.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—urinary bladder cancer	2.65e-05	7.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	2.62e-05	7.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	2.61e-05	7.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—urinary bladder cancer	2.59e-05	7.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—urinary bladder cancer	2.59e-05	7.12e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—urinary bladder cancer	2.57e-05	7.06e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—urinary bladder cancer	2.57e-05	7.06e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	2.55e-05	7.01e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	2.54e-05	6.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—urinary bladder cancer	2.53e-05	6.94e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—urinary bladder cancer	2.52e-05	6.91e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.51e-05	6.9e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1A—urinary bladder cancer	2.51e-05	6.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—urinary bladder cancer	2.51e-05	6.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—urinary bladder cancer	2.51e-05	6.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—urinary bladder cancer	2.5e-05	6.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—urinary bladder cancer	2.47e-05	6.77e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	2.45e-05	6.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—urinary bladder cancer	2.44e-05	6.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—urinary bladder cancer	2.44e-05	6.71e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—urinary bladder cancer	2.44e-05	6.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—urinary bladder cancer	2.43e-05	6.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—urinary bladder cancer	2.43e-05	6.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.43e-05	6.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.43e-05	6.66e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—urinary bladder cancer	2.42e-05	6.65e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—urinary bladder cancer	2.42e-05	6.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	2.4e-05	6.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—urinary bladder cancer	2.39e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—urinary bladder cancer	2.36e-05	6.48e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—urinary bladder cancer	2.33e-05	6.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—urinary bladder cancer	2.33e-05	6.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SRC—urinary bladder cancer	2.32e-05	6.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—urinary bladder cancer	2.31e-05	6.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—urinary bladder cancer	2.31e-05	6.34e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—urinary bladder cancer	2.3e-05	6.33e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	2.28e-05	6.26e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	2.27e-05	6.23e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	2.27e-05	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—urinary bladder cancer	2.26e-05	6.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—urinary bladder cancer	2.26e-05	6.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SRC—urinary bladder cancer	2.24e-05	6.16e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SRC—urinary bladder cancer	2.24e-05	6.16e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	2.23e-05	6.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—urinary bladder cancer	2.2e-05	6.05e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	2.17e-05	5.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	2.11e-05	5.78e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—urinary bladder cancer	2.08e-05	5.71e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.04e-05	5.59e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—urinary bladder cancer	2.03e-05	5.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	2.01e-05	5.53e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—urinary bladder cancer	2.01e-05	5.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—urinary bladder cancer	2.01e-05	5.52e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—urinary bladder cancer	1.97e-05	5.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—urinary bladder cancer	1.97e-05	5.4e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.96e-05	5.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	1.93e-05	5.29e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—urinary bladder cancer	1.92e-05	5.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	1.87e-05	5.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—urinary bladder cancer	1.86e-05	5.1e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—urinary bladder cancer	1.86e-05	5.1e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	1.79e-05	4.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—urinary bladder cancer	1.71e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—urinary bladder cancer	1.65e-05	4.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—urinary bladder cancer	1.65e-05	4.54e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—urinary bladder cancer	1.63e-05	4.48e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.6e-05	4.4e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—urinary bladder cancer	1.58e-05	4.34e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—urinary bladder cancer	1.58e-05	4.34e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.4e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.33e-05	3.66e-05	CbGpPWpGaD
